BHAAAS | Bosnian-Herzegovinian American Academy of Arts and Sciences BHAAAS

High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure

Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis

VROOM trial: Pausing methotrexate doubles antibody response to COVID-19 booster vaccine

Acetazolamide in Acute Decompensated Heart Failure with Volume Overload

Clinical management of COVID-19 patients: living guideline

Dexamethasone in hospitalised COVID-19 patients not on intensive respiratory support

VITAL Findings — A Decisive Verdict on Vitamin D Supplementation

Trial suggests metformin effective at reducing odds of serious outcomes for COVID-19 patients seeking early treatment

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19

Defibrillation Strategies for Refractory Ventricular Fibrillation

Direct oral anticoagulant (DOAC) interference in hemostasis assays

Pfizer Reports Additional Data on PAXLOVID™ Supporting Upcoming New Drug Application Submission to U.S. FDA

Study finds few COVID-19 patients get rebound symptoms after Paxlovid treatment

Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies

Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial

Effectiveness of pulse dose methyl prednisolone in management of COVID 19: A systematic review and meta-analysis of observational studies

IVIG plus Glucocorticoids versus IVIG Alone in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A Systematic Review and Meta-Analysis

Thromboinflammation and Antithrombotics in COVID-19

Paxlovid Significantly Reduces COVID-19 Hospitalizations and Deaths

Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19

Haloperidol for the Treatment of Delirium in ICU Patients

Anticoagulation in COVID-19

COVID-19 and VTE/Anticoagulation: Frequently Asked Questions

Effect of Early Treatment with Ivermectin among Patients with Covid-19

Early Outpatient Treatment for Covid-19 with Convalescent Plasma

Evaluation of science advice during the COVID-19 pandemic in Sweden

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial

Comparison of Clinical Outcome between Dexamethasone and Methyl Prednisolone in Treatment of Moderate to Severe COVID-19: A Systematic Review and Meta-Analysis

Management and outcomes of pregnant women admitted to intensive care unit for severe pneumonia related to SARS-CoV-2 infection: the multicenter and international COVIDPREG study

The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials

RETRACTED ARTICLE: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials

An overview of end–of–life issues in the intensive care unit

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

SARS-CoV-2 Omicron BA.2 Variant Evades Neutralization by Therapeutic Monoclonal Antibodies

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities

Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study

A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation

Anticoagulants for people hospitalised with COVID-19

Grand Rounds March 18: Better Data on Ivermectin Is Finally Here: Results from the TOGETHER Trial (Edward Mills, PhD, FRCP; Craig Rayner, PharmD)

Comparison of Trials Using Ivermectin for COVID-19 Between Regions With High and Low Prevalence of Strongyloidiasis

Does vitamin D supplementation reduce COVID-19 severity?: a systematic review

Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis

Therapeutics and COVID-19: living guideline

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit

Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin

Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study

Critically Ill Adults With Coronavirus Disease 2019 in New Orleans and Care With an Evidence-Based Protocol

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

Could dantrolene be explored as a repurposed drug to treat COVID-19 patients by restoring intracellular calcium homeostasis?

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report

Expert reaction to preprint from the REMAP-CAP trial looking at tocilizumab and sarilumab in critically ill COVID-19 patients

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

COVID-19–related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy

Early High-Dose Vitamin D3 for Critically Ill, Vitamin D–Deficient Patients

Safety and Efficacy of Dexmedetomidine in Acutely Ill Adults Requiring Noninvasive Ventilation: A Systematic Review and Meta-analysis of Randomized Trials

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

NIH COVID-19 Treatment Guidelines for Ivermetacin

Mortality rates of patients with COVID-19 in the intensive care unit: a systematic review of the emerging literature

COVID 19 NIH Treatment Guidelines: Interleukin-6 Inhibitors

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial

PRINCIPLE trial finds no benefit from antibiotics, azithromycin and doxycycline for COVID-19 patients

Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19

COVID Treatment Guidelines NIH: Antithrombotic Therapy in Patients With COVID-19

Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients

Severe Acute Respiratory Syndrome Coronavirus-2 Infections in Critical Care Staff: Beware the Risks Beyond the Bedside

Mayo Clinic Ivermectin (Oral Route)

The Future of Critical Care Lies in Quality Improvement and Education

HPA advice on antipyretics does not contradict NICE

Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU

Anakinra for severe forms of COVID-19

Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with Sepsis

Azithromycin, RECOVERY, and the power of large, simple trials

Nosocomial Infection – Critical Care Medicine

Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus

Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID‑19

Recommendations for inpatient treatment of patients with COVID-19

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Potential health and economic impacts of dexamethasone treatment for patients with COVID-19

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial

Corticosteroids in human lymphocyte-mediated cytotoxic reactions: effects on the kinetics of sensitization and on the cytolytic capacity of effector lymphocytes in vitro

Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection The COVID A to Z Randomized Clinical Trial

Calcifediol Treatment and COVID-19-Related Outcomes

Hypnotic suggestions of safety improve well-being in non-invasively ventilated patients in the intensive care unit

Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19 A Randomized Clinical Trial

Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019

COVID 19 Treatment Guidelines NIH: Anti-SARS-CoV-2 Monoclonal Antibodies

COVID-19 vaccination in our transplant recipients: The time is now

Association of British Neurologists: Guidance on Vaccination for COVID-19 and Neurological Conditions

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial

Nebulised interferon beta-1a for patients with COVID-19

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

Therapeutic Anticoagulation in Critically Ill Patients with Covid-19 – Preliminary Report

Montelukast in hospitalized patients diagnosed with COVID-19

Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19

NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial

A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury

Albumin administration in the acutely ill: what is new and where next?

Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2

Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Short Duration Treatment of Non-severe Community Acquired Pneumonia (PTC)

Blood transfusion strategies and ECMO during the COVID-19 pandemic

Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry

Update to living WHO guideline on drugs for covid-19

NIH Interleukin-6 Inhibitors

Hemoadsorption eliminates remdesivir from the circulation: Implications for the treatment of COVID‐19

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial

Invasive Candida Infections in the ICU: Diagnosis and Therapy

Initial MEWS score to predict ICU admission or transfer of hospitalized patients with COVID-19: A retrospective study

Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis

Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype

Role of favipiravir in the treatment of COVID-19

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Update in COVID-19 2020

Evaluation of Time-Limited Trials Among Critically Ill Patients With Advanced Medical Illnesses and Reduction of Nonbeneficial ICU Treatments

Drug treatments for covid-19: living systematic review and network meta-analysis

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)

Occupational therapy for delirium management in elderly patients without mechanical ventilation in an intensive care unit: A pilot randomized clinical trial

Pharmacokinetics of Glutathione and Its Metabolites in Normal Subjects

Checklist for Early Recognition and Treatment of Acute Illness and Injury: An Exploratory Multicenter International Quality-Improvement Study in the ICUs With Variable Resources

Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup

Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

Tocilizumab in Covid-19 Pneumonia

Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial

Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials

The Care of Children With Cancer During the COVID-19 Pandemic

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Expert reaction to press release from the RECOVERY trial reporting that aspirin does not improve survival for patients hospitalised with COVID-19

Caring for COVID‑19 patients and their relatives with the ICU diary

Multimodal intervention to reduce acquisition of carbapenem-non-susceptible Multimodal intervention to reduce acquisition of carbapenem-non-susceptible Multimodal intervention to reduce acquisition of carbapenem-non-susceptible Gram-negative bacteria in intensive care units in the National Referral Hospital of Indonesia: An interrupted time series study

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial

Ivermectin for preventing and treating COVID‐19

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia

Surviving Covid-19 with Heparin?

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19

Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients;The BaSICS Randomized Clinical Trial

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Fluvoxamine: A Review of Its Mechanism of Action and Its Role in COVID-19

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 A Randomized Clinical Trial

Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report

Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Triasl

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial

Differential effects of prone position in COVID19related ARDS in low and high recruiters

Rodin’s Thinker: An Alternative Position in Awake Patients with COVID-19

Cytokine adsorption in severe, refractory septic shock

The Incidence, Severity, and Management of COVID-19 in Critically Ill Pregnant Individuals

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Essential Emergency and Critical Care: a consensus among global clinical experts

Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids

Management of COVID-19 patients admitted to stepdown or ICU

Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)

Molnupiravir, an Oral Antiviral Treatment for COVID-19

High doses of vitamin D rapidly reduce arterial stiffness in overweight/obese, vitamin-deficient African-Americans

Essential Emergency and Critical Care: a consensus among global clinical experts

The New Antibiotic Mantra—“Shorter Is Better”

A living WHO guideline on drugs for covid-19

Expert reaction to interim analysis of oral antiviral molnupiravir

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients

Administration of a β-Lactam Prior to Vancomycin as the First Dose of Antibiotic Therapy Improves Survival in Patients With Bloodstream Infections

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19. The HEP-COVID Randomized Clinical Trial

Immunosuppressant Effects on the Prognosis of SARS-CoV-2 Infection

Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management

Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial

Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

Baricitinib plus Standard of Care for Hospitalised Adults with COVID-19 on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation: Results of a Randomised, Placebo-Controlled Trial

Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19 - The ACTIV-4B Randomized Clinical Trial

Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

Temporal Trends in ICU Survival for Coronavirus Disease 2019: A Bumpy Road

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine

Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model

Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants

Expert reaction to observational study looking at mortality risk among COVID patients prescribed SSRIs

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults

Dorsal Push and Abdominal Binding Improve Respiratory Compliance and Driving Pressure in Proned Coronavirus Disease 2019 Acute Respiratory Distress Syndrome

Impact of Empirical Antibiotic Regimens on Mortality in Neutropenic Patients with Bloodstream Infection Presenting with Septic Shock

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial

Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 - The HEP-COVID Randomized Clinical Trial

Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

Real-World Effectiveness of Remdesivir in Adults Hospitalized With Coronavirus Disease 2019 (COVID-19): A Retrospective, Multicenter Comparative Effectiveness Study

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

PHarmacist Avoidance or Reductions in Medical Costs in CRITically Ill Adults: PHARM-CRIT Study

The Goldilocks Time for Remdesivir — Is Any Indication Just Right?

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial

Dexamethasone in hospitalised coronavirus-19 patients not on intensive respiratory support

Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis

A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

NIH Clinical Trial Shows Remdesivir Accelerates Recovery from Advanced COVID-19

Late-Onset Neonatal Sepsis in a Patient with Covid-19

Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia

Treat more COVID-19 patients at home

Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

ACE2 angiotensin converting enzyme 2 [ Homo sapiens (human) ]

No Hydroxychloroquine Benefit in Small, Randomized COVID-19 Trial

Minor effects

Liverpool covid interreactions

FDA Approves Use Of Plasma From Recovered Coronavirus Patients To Treat The Sickest Patients

Training and Fit Testing of Health Care Personnel for Reusable Elastomeric Half-Mask Respirators Compared With Disposable N95 Respirators

Ketamine sedation in mechanically ventilated patients

The Use of Povidone Iodine Nasal Spray and Mouthwash During the Current COVID-19 Pandemic May Reduce Cross Infection and Protect Healthcare Workers

COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes

Azythromycin covid

Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province

COVID-19 pneumonia: different respiratory treatment for different phenotypes?

Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics

Ventricular Arrhythmia Risk Due to Hydroxychloroquine-Azithromycin Treatment For COVID-19

Cord tissue mesenchymal stem cells in the treatment of covid -10 pneumonia

Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells

Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia

FDA Approves Phase III Clinical Trial of Tocilizumab for COVID-19 Pneumonia

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)

Respiratory support for COVID-19 patients based on physiological principles

Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff

CDC Removes Prescribing Guidelines for Antimalarial Drugs

FDA Issues Safety Alert Regarding Use of Hydroxychloroquine, Chloroquine for COVID-19

Hydroxychloroquine-COVID-19 study did not meet publishing society’s “expected standard”

Expert reaction to trial of remdesivir in adults

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data

Inhaled Nitric Oxide Explored for COVID-19 Oxygenation

Remdesivir for the Treatment of Covid-19 — Final Report

Hydroxychloroquine in treatment of Covid-1 – What is new?

Expert reaction to the retraction of a Lancet paper on hydroxychloroquine and chloroquine treatment for COVID-19 and the retraction of a NEJM paper on Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19

Effect of Convalescent Plasma Treatment on Time to Clinical Improvement in Patients With Severe COVID-19

Treatment guidelines, dexamethasone

Tocilizumab in patients with severe form of COVID-19

Dexamethasone in treatment of Covid-19

Additional recommendations for the clinical care of patients with covid-19

Interferon

Azithromycin for COVID-19: More Than Just an Antimicrobial?

Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia

Dexamethasone in Hospitalized Patients with Covid-19

Emerging pharmacological therapies for ARDS: COVID‑19 and beyond

Antiviral Immune Responses of Bats: A Review

ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome

N-acetylcysteine prevents the development of gastritis induced by Helicobacter pylori infection

Thiazolidinediones and PPARγ agonists: time for a reassessment

Steroid dosing by biomarker

Dexamethasone in Hospitalized Patients with Covid-19

Prednisone, Hydroxychloroquine best among COVID-19 treatments, claims large Spanish study

Effect of nacon pulmonary damage and microembolism

NAC- A rapid review of effectiveness

Trusting evidence over anecdote: Clinical decision making in the era of covid-19

Convalescent plasma or hiperimmune immunoglobulin for ccovid-19

Cost effectiveness of intensive care in a low resource setting: A prospective cohort of medical critically ill patients

Glutathione as a skin whitening agent: Facts, myths, evidence and controversies

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines

RLF-100 (aviptadil) trial shows rapid recovery in Covid-19 patients

Potential role in respiratory therapeutics

Respiratory follow- up of patients with COVID-19 pneumonia

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

Respiratory follow-up of patients with COVID-19 pneumonia

Hyperbaric oxygen therapy

Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Remdesivir

Therapeutic Management of Hospitalized Adults With COVID-19

Solidarity clinical trial for covid-19 treatment

Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results

High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19)

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Azithromycin for severe COVID-19

Aspirin to be investigated as a possible treatment for COVID-19 in the RECOVERY trial

Anti-SARS-CoV-2 Monoclonal Antibodies: Selected Clinical Data

Misguided Use of Hydroxychloroquine for COVID-19

Update: Eli Lilly’s Anti-COVID Product Approved by FDA

Prone position in ARDS patients: why, when, how and for whom

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study

Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019

Effect of Aspirin on Development of ARDS in At-Risk Patients Presenting to the Emergency Department: The LIPS-A Randomized Clinical Trial

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19

Adequate vitamin D levels in a Swedish population living above latitude 63°N: The 2009 Northern Sweden MONICA study

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review

ACE2 and Hypertension

PRESS RELEASE: Tocilizumab effective in treating sickest COVID-19 patients

A living WHO guideline on drugs for covid-19

WHO group recommends against using remdesivir to treat hospitalized Covid-19 patients

The Zentensivist Manifesto. Defining the Art of Critical Care

Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19)

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses

Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

The impact of monoclonal antibodies and COVID-19 recovery

ICMR permits prophylactic use of hydroxychloroquine for corona virus

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Overview of the status of evaluation and approval of drugs and vaccines

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19

An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19

B Vitamin Supplementation Reduced Serum Homocysteine and Interleukin-6 Levels in Patients with Behcets Disease with Acute Venous Thrombosis: A Prospective Controlled Study

Azithromycin results

Expert reaction to preprint from the RECOVERY trial on the antibiotic azithromycin in patients hospitalised with COVID-19, reporting no benefit

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

A living WHO guideline on drugs for covid-19

COVID-19 rapid guideline: managing the long-term effects of COVID-19

Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE (ACTIV-4A)

Ivermectin

Randomised Study of Plasma Exchange in Severe COVID-19 (COVIPLEX)

Ivermectin in Adults With Severe COVID-19.

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19

Viber Group: COVID-19 Archive

Filter by topic

Epidemiology - 97 articles

Clinical presentation - 14 articles

Diagnosis - 32 articles

Immunization - 198 articles

Therapy - 348 articles

Invasive and Noninvasive Ventilation - 86 articles

Complications including post-covid syndrome - 122 articles

Other - 188 articles

Subscribe to our Newsletter!

[email protected]

Sitemap

BHAAAS Divisions

BHAAAS Programs

Useful Links

Viber Group Covid 19 Archive

Viber Group: COVID-19 Archive

Filter by topic

Epidemiology - 97 articles

Clinical presentation - 14 articles

Diagnosis - 32 articles

Immunization - 198 articles

Therapy - 348 articles

Invasive and Noninvasive Ventilation - 86 articles

Complications including post-covid syndrome - 122 articles

Other - 188 articles

Subscribe to our Newsletter!

[email protected]

Sitemap

BHAAAS Divisions

BHAAAS Programs

Useful Links